FDA-cleared autonomous AI for diabetic retinopathy screening powered by EyeArt.

Detect more than mild and vision-threatening DR in seconds; 
no specialist required.

Bring more patients into view.

The retina is a powerful tool for detection.

Close-up images of different eyes with varying colors and skin tones, arranged in a horizontal row.Six circular images showing close-ups of eyes and colored gradient circles with eye-test target marks.

retinal

DR is a leading cause of preventable blindness in working-age adults. While early intervention halts progression, many lack access to specialists. EyeArt transforms the retina into a proactive tool for early detection, bringing universal, autonomous AI screening into view for every patient.

Scanning

EyeArt offers rapid eye screening for all, without a separate appointment.

One eye exam. Instant visibility.

EyeArt performs autonomous exams at the point of care

No specialist required 

Accurate results, 
delivered in seconds

Built for PCP, endocrinology, optometry, ophthalmology, and more

FDA 510(k)-cleared AI

First and only for both mtmDR and vtDR detection

Multi-camera compatability

Available globally

How clinics use EyeArt

  • Capture retinal images using your clinic’s existing camera during a routine patient visit
  • Analyze with autonomous AI to deliver an actionable diagnostic report in under 30 seconds
  • Sync results directly to the EHR to immediately coordinate specialist referrals or routine follow-up care

Explore Solutions.

SCREENING
TRIAGE
MONITORING
Close-up of a light brown eye with detailed skin texture and wrinkles around the eye.Close-up of a smiling older person's wrinkled eye and surrounding skin.

Transform every eye into
a gateway to understanding.

Start FDA-cleared autonomous diabetic retinopathy screening in your clinic today.

Contact us